Peter Altman - 17 Jun 2026 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Reporting relationship: President and CEO, Director
Issuer ticker: BCDA
Reported as of: 17 Jun 2026
Net transaction value: +$2,043
SEC form: 4
Accepted by SEC: 22 Jun 2026, 06:09:49 UTC
Prior SEC filing: 09 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ David McClung, by power of attorney

Key filing fact

Peter Altman filed Form 4 for BioCardia, Inc. (BCDA) on 22 Jun 2026.

Key facts

This page summarizes Peter Altman's Form 4 filing for BioCardia, Inc. (BCDA).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 22 Jun 2026, 06:09.

Change

Previous filing in this sequence was filed on 09 Jun 2026.
Current net transaction value: +$2,043.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001647542 Primary reporting owner

Altman Peter

Relationship: President and CEO, Director
Address: C/O BIOCARDIA, INC., 320 SOQUEL WAY, SUNNYVALE
Signature: /s/ David McClung, by power of attorney
Signature date: 22 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BCDA transaction

Common Stock

Purchase

Transaction value: $1,275
Shares: +1,500
Change %: +0.5%
Price: $0.8500
Shares after: 299,766
Date: 17 Jun 2026
Ownership: Direct
Footnotes: F1

BCDA transaction

Common Stock

Purchase

Transaction value: $768
Shares: +800
Change %: +0.27%
Price: $0.9600
Shares after: 300,566
Date: 18 Jun 2026
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This transaction was executed in multiple trades ranging from $0.84 to $0.89 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.

Footnote F2

This transaction was executed in multiple trades ranging from $0.98 to $0.96 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.